Better, Faster, Smaller: Personalized Medicine Could Bring R&D Savings

PHILADELPHIA - One near-term benefit of adopting a personalized medicine approach to drug development would be a lower cost for clinical trials by conducting smaller, faster studies that will produce better results and help companies make go/ no go decisions sooner, according to speakers at the Wharton Health Care Business Conference

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet